| Citation: |
LI Na, WANG Xinru, LI Qiang. A Case Report of Primary Tibial T-Cell Lymphoma[J]. Cancer Research on Prevention and Treatment, 2025, 52(3): 247-250. DOI: 10.3971/j.issn.1000-8578.2025.24.0897
|
Competing interests: The authors declare that they have no competing interests.
| [1] |
Liu M, Liu B, Han F, et al. Primary bone lymphoma of the left radius: a case report and related literature review[J]. Eur J Med Res, 2014, 19(1): 19. doi: 10.1186/2047-783X-19-19
|
| [2] |
Zhao XF, Young KH, Frank D, et al. Pediatric primary bone lymphoma-diffuse large B-cell lymphoma: Morphologic and immunohistochemical characteristics of 10 cases[J]. Am J Clin Pathol, 2007, 127(1): 47-54.
|
| [3] |
Messina C, Christie D, Zucca E, et al. Primary and secondary bone lymphomas[J]. Cancer Treat Rev, 2015, 41(3): 235-246. doi: 10.1016/j.ctrv.2015.02.001
|
| [4] |
Wu H, Zhang L, Shao H, et al. Prognostic significance of soft tissue extension, international prognostic index, and multifocality in primary bone lymphoma: a single institutional experience[J]. Br J Haematol, 2014, 166(1): 60-68. doi: 10.1111/bjh.12841
|
| [5] |
Choi JH, Ro JY. The 2020 WHO Classification of Tumors of Bone: An Updated Review[J]. Adv Anat Pathol, 2021, 28(3): 119-138. doi: 10.1097/PAP.0000000000000293
|
| [6] |
Bindal P, Desai A, Delasos L, et al. Primary Bone Lymphoma: A Case Series and Review of Literature[J]. Case Rep Hematol, 2020, 2020: 4254803.
|
| [7] |
Tazi I, Benmoussa A, Boufarissi FZ, et al. Adult non-Hodgkin bone lymphomas[J]. Bull Cancer, 2021, 108(4): 424-434. doi: 10.1016/j.bulcan.2020.12.010
|
| [8] |
Barbon DA, Williams TP, Hulse HB, et al. Primary lymphoma of bone of the little finger: a case report and review of the literature[J]. Skeletal Radiol, 2024, 53(8): 1645-1650. doi: 10.1007/s00256-024-04576-9
|
| [9] |
邱丽萍, 赵小英. 原发性骨淋巴瘤的研究进展[J]. 实用肿瘤杂志, 2018, 33(5): 470-475. [Qiu LP, Zhao XY. The progress of primary bone lymphoma[J]. Shi Yong Zhong Liu Za Zhi, 2018, 33(5): 470-475.]
Qiu LP, Zhao XY. The progress of primary bone lymphoma[J]. Shi Yong Zhong Liu Za Zhi, 2018, 33(5): 470-475.
|
| [10] |
Akahane T, Shimizu T, Isobe KI, et al. Serum soluble interleukin-2 receptor levels in patients with malignant lymphoma of bone[J]. J Orthop Sci, 2009, 14(3): 248-252. doi: 10.1007/s00776-009-1335-x
|
| [11] |
Yabe H, Ueno H, Ochi K, et al. Possible Clinical Significance of Serum Soluble Interleukin-2 Receptor Level in Primary Bone Lymphoma: Two Case Reports[J]. Case Rep Oncol, 2011, 4(1): 125-131. doi: 10.1159/000325399
|
| [12] |
Senjo H, Kanaya M, Izumiyama K, et al. Serum level of soluble interleukin-2 receptor is positively correlated with metabolic tumor volume on 18F-FDG PET/CT in newly diagnosed patients with diffuse large B-cell lymphoma[J]. Cancer Med, 2019, 8(3): 953-962. doi: 10.1002/cam4.1973
|
| [13] |
Kitagawa J, Hara T, Tsurumi H, et al. Serum-soluble interleukin-2 receptor (sIL-2R) is an extremely strong prognostic factor for patients with peripheral T-cell lymphoma, unspecified (PTCL-U)[J]. J Cancer Res Clin Oncol, 2009, 135(1): 53-59. doi: 10.1007/s00432-008-0440-0
|
| [14] |
Morita-Fujita M, Katoh D, Shimomura Y, et al. High Level of Serum Soluble Interleukin-2 Receptor Is Associated With Poor Survival in Patients With First Relapsed or Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Retrospective Study[J]. Clin Lymphoma Myeloma Leuk, 2019, 19(7): e337-e342. doi: 10.1016/j.clml.2019.03.031
|
| [15] |
Ramadan KM, Shenkier T, Sehn LH, et al. A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency[J]. Ann Oncol, 2007, 18(1): 129-135. doi: 10.1093/annonc/mdl329
|
| [16] |
Liu CX, Xu TQ, Xu L, et al. Primary lymphoma of bone: a population-based study of 2558 patients[J]. Ther Adv Hematol, 2020, 11: 2040620720958538.
|
| [17] |
Yu S, Xu J. Imaging Features of Primary T Cell Lymphoma in Bone: A Case Report and Review of Literature[J]. Front Oncol, 2021, 11: 690819. doi: 10.3389/fonc.2021.690819
|
| [18] |
Beal K, Allen L, Yahalom J. Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients[J]. Cancer, 2006, 106(12): 2652-2656. doi: 10.1002/cncr.21930
|
| [19] |
Nguyen CB, Li M, Verstovsek G, et al. Primary bone lymphoma of the ilium successfully treated without radiation[J]. Clin Case Rep, 2020, 8(12): 3130-3133.
|
| [20] |
Wang HH, Dai KN, Li AB. A Nomogram Predicting Overall and Cancer-Specific Survival of Patients with Primary Bone Lymphoma: A Large Population-Based Study[J]. Biomed Res Int, 2020, 2020: 4235939. doi: 10.1155/2020/4235939
|
| [21] |
Horwitz SM, Ansell S, Ai WZ, et al. T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2022, 20(3): 285-308. doi: 10.6004/jnccn.2022.0015
|
| [22] |
Rodriguez J, Conde E, Gutierrez A, et al. The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience[J]. Ann Oncol, 2007, 18(4): 652-657. doi: 10.1093/annonc/mdl466
|
| [23] |
仲凯励, 曹宝平, 郭晓川, 等. 初治原发性骨淋巴瘤患者的临床特征和长期预后分析[J]. 中国实验血液学杂志, 2022, 30(1): 126-130. [Zhong KL, Cao BP, Guo XC, et al. Clinical Characteristics and Long-term Prognosis Analysis of Patients with Primary Bone Lymphoma[J]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2022, 30(1): 126-130.]
Zhong KL, Cao BP, Guo XC, et al. Clinical Characteristics and Long-term Prognosis Analysis of Patients with Primary Bone Lymphoma[J]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2022, 30(1): 126-130.
|
Figures(2)
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: